Stocks and Investing Stocks and Investing
Thu, September 15, 2016
[ 09:46 AM ] - WOPRAI
xG Technology Inc. (NASDAQ:XGTI), Down After BUYI .. k Would Go Down Due To Conditions Outlined In Our
[ 09:45 AM ] - WOPRAI
Gevo Inc. (NASDAQ:GEVO), Down After BUYINS.NET Re .. Go Down Due To Conditions Outlined In Our Report
[ 09:45 AM ] - WOPRAI
JAKKS Pacific Inc. (NASDAQ:JAKK), Down After BUYI .. k Would Go Down Due To Conditions Outlined In Our
[ 09:45 AM ] - WOPRAI
Utah Medical Products Inc. (NASDAQ:UTMD), Down Af .. ed Stock Would Go Down Due To Conditions Outlined
[ 09:45 AM ] - WOPRAI
Asantae Holdings International Inc (NASDAQ:JVA), .. Predicted Stock Would Go Down Due To Conditions O
[ 09:45 AM ] - WOPRAI
ANTH SqueezeTrigger Price is $3.29. There is $15,486,359 That Short Sellers Still Need To Cover.
[ 09:45 AM ] - WOPRAI
STWD SqueezeTrigger Price is $22.65. There is $194,298,495 That Short Sellers Still Need To Cover.
[ 09:45 AM ] - WOPRAI
APT SqueezeTrigger Price is $2.97. There is $87,278 That Short Sellers Still Need To Cover.
[ 07:46 AM ] - WOPRAI
Amber Road Inc. (NYSE:AMBR), Down After BUYINS.NE .. d Go Down Due To Conditions Outlined In Our Repor
[ 07:46 AM ] - WOPRAI
Cobalt International Energy Inc. (NYSE:CIE), Down .. icted Stock Would Go Down Due To Conditions Outli
[ 07:46 AM ] - WOPRAI
Neuralstem Inc. (NASDAQ:CUR), Down After BUYINS.N .. ld Go Down Due To Conditions Outlined In Our Repo
[ 07:45 AM ] - WOPRAI
CLARCOR Inc. (NYSE:CLC) Down By 7.93% ($5.07) Fro .. YINS.NET Report Predicted Strength After Earnings
[ 07:45 AM ] - WOPRAI
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), Up By .. ET SqueezeTrigger Report Released on Wednesday, S
[ 07:45 AM ] - WOPRAI
Dipexium Pharmaceuticals (NASDAQ:DPRX), Up By $3. .. SqueezeTrigger Report Released on Friday, August
[ 07:45 AM ] - WOPRAI
Aerie Pharmaceuticals (NASDAQ:AERI), Up By $15.46 .. ueezeTrigger Report Released on Friday, September
[ 07:45 AM ] - WOPRAI
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Up .. .NET SqueezeTrigger Report Released on Monday, Se
[ 07:45 AM ] - WOPRAI
La Jolla Pharmaceutical Company (NASDAQ:LJPC), Up .. icted Stock Would Go Up Due To Conditions Outline
[ 07:45 AM ] - WOPRAI
ATRC SqueezeTrigger Price is $15.75. There is $36,233,816 That Short Sellers Still Need To Cover.
[ 06:45 AM ] - WOPRAI
STEM, PSCC, Removed From Naked Short Lists Today
[ 04:45 AM ] - WOPRAI
DRAD, PHX, CNBKA, USAT, JMP, Expected to Trade Higher After Bullish Insider Trading
[ 04:45 AM ] - WOPRAI
FGEN, NEWR, SHAK, Expected to Trade Lower After Bearish Insider Trading
[ 04:45 AM ] - WOPRAI
EPAY, ZIXI, HMSY, SLAB, GRUB, TNAV, Expected to Trade Lower After Bearish Insider Trading
[ 12:46 AM ] - WOPRAI
FINL Expected To Be Down Before Next Earnings Releases
[ 12:45 AM ] - WOPRAI
HTM, BBW, PIY, PKG, LEA, SHO Are Seasonally Ripe To Go Down In the Next Five Weeks
[ 12:45 AM ] - WOPRAI
AAV, EBS, RBL, RWR, IYG, AFG Are Seasonally Ripe To Go Down In the Next Five Weeks
[ 12:45 AM ] - WOPRAI
UEC, ATHX, SB, ASCMA, BGCP, DANG Are Seasonally Ripe To Go Down In the Next Five Weeks
[ 12:45 AM ] - WOPRAI
TEAR, CIE, CALX, AOSL, FN, USCR Are Seasonally Ripe To Go Down In the Next Five Weeks
[ 12:45 AM ] - WOPRAI
AGG, DXB, BND, DTK Are Seasonally Ripe To Go Up In the Next Five Weeks
[ 12:00 AM ] - WOPRAI
Romit Shah Maintained (AVGO) at Strong Buy with Decreased Target to $18 on, Sep 15th, 2016
[ 12:00 AM ] - WOPRAI
Dave Rochester Maintained (WBS) at Strong Buy with Increased Target to $42 on, Sep 15th, 2016

Dave Rochester Maintained (WBS) at Strong Buy with Increased Target to $42 on, Sep 15th, 2016


Published on 2024-10-25 18:31:59 - WOPRAI, Dave Rochester
  Print publication without navigation


Dave Rochester of Deutsche Bank, Maintained "Webster Financial Corporation" (WBS) at Strong Buy with Increased Target from $39 to $42 on, Sep 15th, 2016.

Dave has made no other calls on WBS in the last 4 months.



There are 2 other peers that have a rating on WBS. Out of the 2 peers that are also analyzing WBS, 1 agrees with Dave's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Matthew Keating of "Barclays" Downgraded from Buy to Hold and Held Target at $38 on, Friday, August 5th, 2016


This is the rating of the analyst that currently disagrees with Dave

  • Steven Alexopoulos of "JP Morgan" Maintained at Buy with Decreased Target to $38 on, Thursday, July 7th, 2016
Contributing Sources